CLINICAL_TRIALS ClinicalTrials.gov record update

TRUST-2: An Open-label Continuation Trial of the Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03055221
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:23.290367+00:00
Published At: 2017-07-28T00:00:00+00:00
Record Updated At: 2024-01-05
Results Posted At: 2017-07-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pulmonary Arterial Hypertension"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-01-05"
protocolSection.identificationModule.nctId: "NCT03055221"
protocolSection.identificationModule.officialTitle: "TRUST-2: An Open-label Continuation Trial of the Safety and Efficacy of Intravenous Remodulin\u00ae in Patients in India With Pulmonary Arterial Hypertension (PAH)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-07-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.